Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04610788 · ClinicalTrials.gov registry record
Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH
A clinical trial, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 43
- Enrollment target
NCT04610788: Completed study, sponsored by Johns Hopkins University.
NCT04610788 is a clinical trial that has completed, run by Johns Hopkins University. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04610788 has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
This observational study is being done to understand why people with scleroderma can develop pulmonary arterial hypertension (high blood pressure in the lungs, abbreviated PAH) and a weak heart muscle (heart failure). The study will also help the investigators understand why people with PAH from an unknown cause (called idiopathic PAH, or IPAH) can also develop a weakened heart muscle. The response of the right side of the heart or right ventricle (RV) to standard PAH therapy in scleroderma-associated PAH and in IPAH will be assessed. Blood and tissue samples will be collected from research participants during participants' normal standard of care procedures. People with scleroderma-associated PAH or idiopathic cause (IPAH) who need a right heart catheterization may join this study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2025-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04610788
The ClinicalTrials.gov registry entry for NCT04610788 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04610788 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04610788 about?
NCT04610788 is a clinical study titled "Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH". This observational study is being done to understand why people with scleroderma can develop pulmonary arterial hypertension (high blood pressure in the lungs, abbreviated PAH) and a weak heart muscle (heart failure). The study will also help the investigators understand why people with PAH from an ...
What is the current status of trial NCT04610788?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2019-04-15. Estimated completion is 2025-12-31.
Who is sponsoring clinical trial NCT04610788?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.